iRhythm Technologies, Inc.   Report issue

For profit Phase 4
Founded: San Francisco CA United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2017
NCT03168529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now